{arrow_up} Back to top

Risk Minimisation Materials

Search by company, common medicine name, or title of Risk Minimisation Material

Assicco

Morningside Healthcare Ltd

{pdf_link}

Glycopyrronium Bromide Tablets Patient Alert Card

The patient alert card is an aid which helps to provide the patient’s caregiver with essential information on the administration of Glycopyrronium bromide tablets and the management and minimisation of side effects. It is important that this card is given to the treating doctor to record guidance on dosing.

Glycopyrronium

Colonis Pharma Ltd

{pdf_link}

Checklist for Healthcare Professionals for Glycopyrronium Bromide 1 mg/5 ml - Risk minimisation of anticholinergic side effects

{healthcare_pro_orange} For Healthcare Professionals
Checklist for assessment of anticholinergic effects table. Important information to be brought to the attention of the parent/caregiver. Additional points to emphasise.

{pdf_link}

Reminder Card for Caregivers - Glycopyrronium Bromide 1 mg/5 ml Oral Solution

How to manage common side effects. Important information on the administration of Glycopyrronium Bromide 1 mg/5 ml Oral Solution. Dose administration table to be completed by the doctor. How to manage important side effects. Additional information.

Sovereign Medical

{pdf_link}

Glycopyrronium - Reminder Card for caregivers

{healthcare_pro_orange} For Healthcare Professionals

Reminder card for Caregivers of Glycopyrronium Bromide 1 mg and 2 mg Tablets.

These materials have been designed to support you in the appropriate administration of Glycopyrronium Bromide 1 mg and 2 mg Tablets for the symptomatic treatment of severe sialorrhoea (chronic pathological drooling) in children and adolescents aged 3 years and older with chronic neurological disorders.

It is recommended that these materials be used in conjunction with the full prescribing information for the product.


{pdf_link}

Glycopyrronium HCP Checklist

{healthcare_pro_orange} For Healthcare Professionals

Educational materials for Glycopyrronium Bromide 1 mg and 2 mg Tablets. These materials have been designed to support you in the appropriate prescription and administration of Glycopyrronium Bromide 1 mg and 2 mg Tablets for the symptomatic treatment of severe sialorrhoea (chronic pathological drooling) in children and adolescents aged 3 years and older with chronic neurological disorders.

It is recommended that these materials be used in conjunction with the full prescribing information for the product.


Glycopyrronium bromide

Dawa Limited

{external_link}

Healthcare Professional (HCP) Checklist

{healthcare_pro_orange} For Healthcare Professionals
The healthcare professional (HCP) checklist is an aid to help you evaluate and discuss the risks associated with glycopyrronium bromide tablets with the patient’s carer. It provides important information on the management and minimisation of side effects.

{external_link}

Patient Alert Card - for Caregivers

This patient alert card is an aid which helps to provide the patient’s caregiver with essential information on the administration of glycopyrronium bromide tablets and the management and minimisation of side effects. It is important that this card is given to the treating doctor to record guidance on dosing.

Morningside Healthcare Ltd

{pdf_link}

Glycopyrronium Bromide Tablets Patient Alert Card

The patient alert card is an aid which helps to provide the patient’s caregiver with essential information on the administration of Glycopyrronium bromide tablets and the management and minimisation of side effects. It is important that this card is given to the treating doctor to record guidance on dosing.

{pdf_link}

HEALTHCARE PROFESSIONAL (HCP) CHECKLIST

{healthcare_pro_orange} For Healthcare Professionals
The healthcare professional (HCP) checklist is an aid to help you evaluate and discuss the risks associated with glycopyrronium bromide tablets with the patient’s carer. It provides important information on the management and minimisation of side effect.

Rosemont Pharmaceuticals Limited

{pdf_link}

Checklist for Healthcare Professionals

{healthcare_pro_orange} For Healthcare Professionals
These educational materials focus on the provision of advice for the recognition of anticholinergic effects that can be associated with glycopyrronium bromide containing products and how best to manage specific events.

{pdf_link}

Reminder Card for Caregivers

These educational materials focus on the provision of advice for the recognition of anticholinergic effects that can be associated with glycopyrronium bromide containing products and how best to manage specific events.

Strandhaven Limited t/a Somex Pharma

{pdf_link}

Checklist for Healthcare Professionals for Glycopyrronium bromide 1mg/5ml Oral Solution (Somex)

{healthcare_pro_orange} For Healthcare Professionals
The healthcare professional (HCP) checklist is an aid to help you evaluate and discuss the risks associated with glycopyrronium bromide oral solution with the patient’s carer. It provides important information on the management and minimisation of side effects.

{pdf_link}

Glycopyrronium Bromide (Somex) HCP Checklist

{healthcare_pro_orange} For Healthcare Professionals
"The healthcare professional (HCP) checklist is an aid to help you evaluate and discuss the risks associated with glycopyrronium bromide tablets with the patient’s carer. It provides important information on the management and minimisation of side effects."

{pdf_link}

Glycopyrronium Bromide (Somex) Patient Alert Card

{healthcare_pro_orange} For Healthcare Professionals
"This patient alert card is an aid which helps to provide the patient’s caregiver with essential information on the administration of glycopyrronium bromide tablets and the management and minimisation of side effects."

{pdf_link}

Glycopyrronium bromide 1mg/5ml Oral Solution (Somex) Patient Alert Card

{healthcare_pro_orange} For Healthcare Professionals
This patient alert card is an aid that helps to provide the patient’s caregiver with essential information on the administration of glycopyrronium bromide oral solution and the management and minimisation of side effects. This card must be given to the treating doctor to record guidance on dosing

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?